Blog

India and China: A Tale of Two Markets with Different Fundamentals

Introduction to the Indian and Chinese Markets The Indian and Chinese stock markets have been making headlines in recent times, with China experiencing a resurgence in its stock market, while India has been underperforming. According to Mark Matthews, Head of Research Asia at Julius Baer, these two markets are driven by different fundamentals and opportunities, […]

Blog

Lenskart IPO: Ambit Gives Sell Rating, Cites Valuation Concerns

Lenskart IPO: Ambit Gives Sell Rating, Cites Valuation Concerns Lenskart, the popular eyewear retailer, is set to list on the Indian stock markets on Monday, but has already received its first sell rating from Ambit, a leading brokerage firm. The rating comes as a surprise, given Lenskart’s strong brand and growth prospects. However, Ambit believes

Blog

Indoco Remedies Q2 Review: Dolat Capital Revises Target Price, Maintains ‘Sell’ Rating

Indoco Remedies Q2 Review: A Mixed Bag for Investors Indoco Remedies Ltd., a leading Indian pharmaceutical company, recently announced its Q2 FY26 earnings, which came in above estimates. However, despite the positive earnings surprise, Dolat Capital has downgraded its Ebitda estimates and maintained a ‘Sell’ rating with a revised target price of Rs 224. Q2

Blog

P&G Hygiene and Healthcare Ltd. Q2 Review: Understanding the Impact of Weak Gross Margins on Profitability

P&G Hygiene and Healthcare Ltd. Q2 Review: Key Highlights and Takeaways P&G Hygiene and Healthcare Ltd., a leading player in the Indian hygiene and healthcare sector, recently announced its Q2 results. The company’s performance was marred by weak gross margins, which had a significant impact on its profitability. In this article, we will delve into

Scroll to Top